$TXN
Texas Instruments Inc

2020 Q1 Form 10-Q Financial Statement

#000009747620000017 Filed on April 22, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $3.329B $3.594B
YoY Change -7.37% -5.15%
Cost Of Revenue $1.241B $1.333B
YoY Change -6.9% -0.67%
Gross Profit $2.088B $2.261B
YoY Change -7.65% -7.6%
Gross Profit Margin 62.72% 62.91%
Selling, General & Admin $417.0M $414.0M
YoY Change 0.72% -4.39%
% of Gross Profit 19.97% 18.31%
Research & Development $377.0M $389.0M
YoY Change -3.08% 1.04%
% of Gross Profit 18.06% 17.2%
Depreciation & Amortization $186.0M $166.0M
YoY Change 12.05% -27.51%
% of Gross Profit 8.91% 7.34%
Operating Expenses $794.0M $803.0M
YoY Change -1.12% -1.83%
Operating Profit $1.244B $1.379B
YoY Change -9.79% -10.92%
Interest Expense -$45.00M -$38.00M
YoY Change 18.42% 65.22%
% of Operating Profit -3.62% -2.76%
Other Income/Expense, Net $25.00M $36.00M
YoY Change -30.56% 28.57%
Pretax Income $1.224B $1.377B
YoY Change -11.11% -11.33%
Income Tax $50.00M $160.0M
% Of Pretax Income 4.08% 11.62%
Net Earnings $1.174B $1.217B
YoY Change -3.53% -10.91%
Net Earnings / Revenue 35.27% 33.86%
Basic Earnings Per Share $1.25 $1.29
Diluted Earnings Per Share $1.24 $1.26
COMMON SHARES
Basic Shares Outstanding 931.0M shares 939.0M shares
Diluted Shares Outstanding 943.0M shares 956.0M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.742B $4.086B
YoY Change 16.05% 0.17%
Cash & Equivalents $2.518B $3.720B
Short-Term Investments $2.224B $366.0M
Other Short-Term Assets $249.0M $294.0M
YoY Change -15.31% -71.32%
Inventory $2.003B $2.131B
Prepaid Expenses
Receivables $1.316B $1.440B
Other Receivables $0.00 $0.00
Total Short-Term Assets $8.310B $7.951B
YoY Change 4.52% -7.44%
LONG-TERM ASSETS
Property, Plant & Equipment $3.233B $3.664B
YoY Change -11.76% 33.92%
Goodwill $4.360B
YoY Change
Intangibles
YoY Change
Long-Term Investments $34.00M $308.0M
YoY Change -88.96% 4.41%
Other Assets $493.0M $511.0M
YoY Change -3.52% -8.09%
Total Long-Term Assets $8.973B $9.492B
YoY Change -5.47% 6.45%
TOTAL ASSETS
Total Short-Term Assets $8.310B $7.951B
Total Long-Term Assets $8.973B $9.492B
Total Assets $17.28B $17.44B
YoY Change -0.92% -0.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $363.0M $477.0M
YoY Change -23.9% -2.25%
Accrued Expenses $905.0M $819.0M
YoY Change 10.5% 10.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.051B $750.0M
YoY Change 40.13% 50.0%
Total Short-Term Liabilities $2.381B $2.159B
YoY Change 10.28% 16.08%
LONG-TERM LIABILITIES
Long-Term Debt $5.499B $5.057B
YoY Change 8.74% 41.34%
Other Long-Term Liabilities $1.510B $1.545B
YoY Change -2.27% 12.45%
Total Long-Term Liabilities $7.009B $1.545B
YoY Change 353.66% -68.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.381B $2.159B
Total Long-Term Liabilities $7.009B $1.545B
Total Liabilities $9.549B $8.924B
YoY Change 7.0% 29.99%
SHAREHOLDERS EQUITY
Retained Earnings $40.23B
YoY Change
Common Stock $3.837B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $36.00B
YoY Change
Treasury Stock Shares 819.3M shares
Shareholders Equity $7.734B $8.519B
YoY Change
Total Liabilities & Shareholders Equity $17.28B $17.44B
YoY Change -0.92% -0.37%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $1.174B $1.217B
YoY Change -3.53% -10.91%
Depreciation, Depletion And Amortization $186.0M $166.0M
YoY Change 12.05% -27.51%
Cash From Operating Activities $851.0M $1.107B
YoY Change -23.13% -0.45%
INVESTING ACTIVITIES
Capital Expenditures $161.0M $251.0M
YoY Change -35.86% -232.8%
Acquisitions
YoY Change
Other Investing Activities $5.000M $13.00M
YoY Change -61.54% -97.14%
Cash From Investing Activities $826.0M $1.173B
YoY Change -29.58% 340.98%
FINANCING ACTIVITIES
Cash Dividend Paid $841.0M $724.0M
YoY Change 16.16% 18.49%
Common Stock Issuance & Retirement, Net $1.641B $1.152B
YoY Change 42.45% 31.96%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.596B -$998.0M
YoY Change 59.92% -24.22%
NET CHANGE
Cash From Operating Activities $851.0M $1.107B
Cash From Investing Activities $826.0M $1.173B
Cash From Financing Activities -$1.596B -$998.0M
Net Change In Cash $81.00M $1.282B
YoY Change -93.68% 2001.64%
FREE CASH FLOW
Cash From Operating Activities $851.0M $1.107B
Capital Expenditures $161.0M $251.0M
Free Cash Flow $690.0M $856.0M
YoY Change -19.39% -34.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000097476
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-0289970
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-03761
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
TEXAS INSTRUMENTS INCORPORATED
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
12500 TI Boulevard
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75243
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei City Area Code
CityAreaCode
214
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
479-3773
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $1.00
CY2020Q1 dei Trading Symbol
TradingSymbol
TXN
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
917772641 shares
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3329000000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3594000000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1241000000 USD
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1333000000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
2088000000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
2261000000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
377000000 USD
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
389000000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
417000000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
414000000 USD
CY2020Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
50000000 USD
CY2019Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
79000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1244000000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1379000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25000000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36000000 USD
CY2020Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
45000000 USD
CY2019Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
38000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1224000000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1377000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1217000000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.25
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.24
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
931000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
939000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
943000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
956000000 shares
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1217000000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
6000000 USD
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
8000000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1168000000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1209000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1193000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-3000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
1000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
9000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-2000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1217000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
-2000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
-3000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-8000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-10000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
19000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1225000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2518000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2437000000 USD
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
2224000000 USD
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
2950000000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8000000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8000000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1316000000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1074000000 USD
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
175000000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
176000000 USD
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
915000000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
916000000 USD
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
913000000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
909000000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
2003000000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2503000000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
2001000000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
249000000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
299000000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
8310000000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
8761000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5736000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5740000000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2437000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3233000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3303000000 USD
CY2020Q1 us-gaap Long Term Investments
LongTermInvestments
34000000 USD
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
300000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
4362000000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
4362000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
290000000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
340000000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
208000000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
197000000 USD
CY2020Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
138000000 USD
CY2019Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
69000000 USD
CY2020Q1 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
215000000 USD
CY2019Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
218000000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
493000000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
468000000 USD
CY2020Q1 us-gaap Assets
Assets
17283000000 USD
CY2019Q4 us-gaap Assets
Assets
18018000000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1051000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
500000000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
363000000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
388000000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
353000000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
714000000 USD
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
62000000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
46000000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
552000000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
475000000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2381000000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2123000000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5499000000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5303000000 USD
CY2020Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
95000000 USD
CY2019Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
93000000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
64000000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
78000000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1510000000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1514000000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
9549000000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
9111000000 USD
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2400000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2400000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1740815939 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1740815939 shares
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
1741000000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1741000000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2096000000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2110000000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
40227000000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39898000000 USD
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
819335097 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
808784381 shares
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
36002000000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
34495000000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-328000000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-347000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
7734000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8907000000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17283000000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18018000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1217000000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
186000000 USD
CY2019Q1 us-gaap Depreciation
Depreciation
166000000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50000000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79000000 USD
CY2020Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
14000000 USD
CY2019Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
13000000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
63000000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
61000000 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2019Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
2000000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-34000000 USD
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
242000000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
233000000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2000000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-86000000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
88000000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-223000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-67000000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-353000000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-373000000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
147000000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-94000000 USD
CY2020Q1 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
27000000 USD
CY2019Q1 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
7000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
91000000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-20000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
851000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1107000000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
161000000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
251000000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2019Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2000000 USD
CY2020Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
646000000 USD
CY2019Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
149000000 USD
CY2020Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1638000000 USD
CY2019Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1584000000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5000000 USD
CY2019Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
13000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
826000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1173000000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
749000000 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
743000000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
841000000 USD
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
724000000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1641000000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1152000000 USD
CY2020Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
146000000 USD
CY2019Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
151000000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-9000000 USD
CY2019Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-16000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1596000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-998000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
81000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1282000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2437000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2438000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2518000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3720000000 USD
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportable_segment
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3329000000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3594000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1244000000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1379000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3329000000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3594000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1217000000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
6000000 USD
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
8000000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1168000000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
931000000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.25
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1209000000 USD
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
939000000 shares
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12000000 shares
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
17000000 shares
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1217000000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
6000000 USD
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
8000000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1168000000 USD
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
943000000 shares
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.24
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1209000000 USD
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
956000000 shares
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000000 shares
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000000 shares
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
6550000000 USD
CY2020Q1 txn Estimated Annual Effective Income Tax Rate Continuing Operations
EstimatedAnnualEffectiveIncomeTaxRateContinuingOperations
0.14
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q1 txn Income Tax Reconciliation Income Tax Expense Benefit At Estimated Annual Effective Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtEstimatedAnnualEffectiveIncomeTaxRate
166000000 USD
CY2019Q1 txn Income Tax Reconciliation Income Tax Expense Benefit At Estimated Annual Effective Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtEstimatedAnnualEffectiveIncomeTaxRate
220000000 USD
CY2020Q1 txn Income Tax Reconciliation Discrete Tax Items
IncomeTaxReconciliationDiscreteTaxItems
116000000 USD
CY2019Q1 txn Income Tax Reconciliation Discrete Tax Items
IncomeTaxReconciliationDiscreteTaxItems
60000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160000000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.04
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.12
CY2020Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2518000000 USD
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
2224000000 USD
CY2020Q1 us-gaap Long Term Investments
LongTermInvestments
34000000 USD
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1390000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2437000000 USD
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
2950000000 USD
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
300000000 USD
CY2020Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0 USD
CY2019Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0 USD
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1580000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
4368000000 USD
CY2020Q1 txn Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
20000000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
253000000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
4360000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
4360000000 USD
CY2019Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50000000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79000000 USD
CY2020Q1 us-gaap Commercial Paper
CommercialPaper
0 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6600000000 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5850000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
500000000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5499000000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5303000000 USD
CY2020Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
45000000 USD
CY2019Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
38000000 USD
CY2020Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
50000000 USD
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
47000000 USD
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
6550000000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
5803000000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1051000000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.90
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.90
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.77
CY2019Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.77
CY2020Q1 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
Contingencies<div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Indemnification guarantees</span></div><div style="margin-top:12pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Warranty costs/product liabilities</span></div><div style="margin-top:12pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">General</span></div><div style="margin-top:12pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity.</span></div>
CY2020Q1 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Indemnification guarantees</span></div><div style="margin-top:12pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Warranty costs/product liabilities</span></div><div style="margin-top:12pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.</span></div>
CY2020Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
5214242 shares

Files In Submission

Name View Source Status
0000097476-20-000017-index-headers.html Edgar Link pending
0000097476-20-000017-index.html Edgar Link pending
0000097476-20-000017.txt Edgar Link pending
0000097476-20-000017-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q12020txnex31a.htm Edgar Link pending
q12020txnex31b.htm Edgar Link pending
q12020txnex32a.htm Edgar Link pending
q12020txnex32b.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
txn-20200331.htm Edgar Link pending
txn-20200331.xsd Edgar Link pending
txn-20200331_cal.xml Edgar Link unprocessable
txn-20200331_def.xml Edgar Link unprocessable
txn-20200331_htm.xml Edgar Link completed
txn-20200331_lab.xml Edgar Link unprocessable
txn-20200331_pre.xml Edgar Link unprocessable